CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 249318-249416 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1933","span":{"begin":0,"end":98},"obj":"Sentence"},{"id":"T9669","span":{"begin":0,"end":98},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Adverse events (AEs) occurring in 3% of subjects in either treatment arm were nausea and vomiting."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T32","span":{"begin":0,"end":98},"obj":"Sentence"}],"text":"Adverse events (AEs) occurring in 3% of subjects in either treatment arm were nausea and vomiting."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T248","span":{"begin":78,"end":97},"obj":"Phenotype"}],"attributes":[{"id":"A248","pred":"hp_id","subj":"T248","obj":"http://purl.obolibrary.org/obo/HP_0002017"}],"text":"Adverse events (AEs) occurring in 3% of subjects in either treatment arm were nausea and vomiting."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T204","span":{"begin":69,"end":72},"obj":"Body_part"}],"attributes":[{"id":"A204","pred":"uberon_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/UBERON_0001460"}],"text":"Adverse events (AEs) occurring in 3% of subjects in either treatment arm were nausea and vomiting."}